(Q43698528)

English

Protective immune response against cutaneous leishmaniasis by prime/booster immunization regimens with vaccinia virus recombinants expressing Leishmania infantum p36/LACK and IL-12 in combination with purified p36.

scientific article published in July 2001

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

26 November 2017

Protective immune response against cutaneous leishmaniasis by prime/booster immunization regimens with vaccinia virus recombinants expressing Leishmania infantum p36/LACK and IL-12 in combination with purified p36. (English)

1 reference

Europe PubMed Central

26 November 2017

0 references

Leishmania infantum

1 reference

based on heuristic

inferred from title

cutaneous leishmaniasis

1 reference

based on heuristic

inferred from title

object named as

vaccinia virus

1 reference

based on heuristic

inferred from title

Mariano Esteban

6

object named as

M Esteban

1 reference

Europe PubMed Central

26 November 2017

author name string

R M Gonzalo

1

1 reference

Europe PubMed Central

26 November 2017

J R Rodríguez

2

1 reference

Europe PubMed Central

26 November 2017

D Rodríguez

3

1 reference

Europe PubMed Central

26 November 2017

G González-Aseguinolaza

4

1 reference

Europe PubMed Central

26 November 2017

V Larraga

5

1 reference

Europe PubMed Central

26 November 2017

publication date

1 July 2001

1 reference

Europe PubMed Central

26 November 2017

Microbes and Infection

1 reference

Europe PubMed Central

26 November 2017

3

1 reference

Europe PubMed Central

26 November 2017

9

1 reference

Europe PubMed Central

26 November 2017

701-711

1 reference

Europe PubMed Central

26 November 2017

Immunology of leishmaniasis

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901426-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Cellular and humoral immune responses in dogs experimentally and naturally infected with Leishmania infantum

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901426-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Leishmania infantum-specific T cell lines derived from asymptomatic dogs that lyse infected macrophages in a major histocompatibility complex-restricted manner.

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901426-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Human TH1 and TH2 subsets: doubt no more

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901426-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Resolution of cutaneous leishmaniasis: interleukin 12 initiates a protective T helper type 1 immune response

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901426-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Interleukin-12: a proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901426-5

7 January 2021

based on heuristic

inferred from DOI database lookup

IL-12 is required to maintain a Th1 response during Leishmania major infection.

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901426-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Leishmania pifanoi amastigote antigens protect mice against cutaneous leishmaniasis.

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901426-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Expression cloning of a protective Leishmania antigen

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901426-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Recombinant vaccinia viruses expressing GP46/M-2 protect against Leishmania infection

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901426-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Selective down-regulation of Th2 immune responses following treatment with antigen-coupled splenocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901426-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Resistance to Leishmania major induced by tolerance to a single antigen

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901426-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Vaccination with DNA encoding the immunodominant LACK parasite antigen confers protective immunity to mice infected with Leishmania major

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901426-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Applications of pox virus vectors to vaccination: an update

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901426-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Molecular cloning, cell localization and binding affinity to DNA replication proteins of the p36/LACK protective antigen from Leishmania infantum

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901426-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Cloning, molecular analysis and differential cell localisation of the p36 RACK analogue antigen from the parasite protozoon Crithidia fasciculata

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901426-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Early parasite containment is decisive for resistance to Leishmania major infection.

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901426-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Compact, synthetic, vaccinia virus early/late promoter for protein expression.

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901426-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Isolation and characterization of attenuated mutants of vaccinia virus

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901426-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Culture microtitration: a sensitive method for quantifying Leishmania infantum in tissues of infected mice

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901426-5

7 January 2021

based on heuristic

inferred from DOI database lookup

The role of antigen and IL-12 in sustaining Th1 memory cells in vivo: IL-12 is required to maintain memory/effector Th1 cells sufficient to mediate protection to an infectious parasite challenge

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901426-5

7 January 2021

based on heuristic

inferred from DOI database lookup

A striking property of recombinant poxviruses: efficient inducers of in vivo expansion of primed CD8(+) T cells

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901426-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Immunization of susceptible hosts with a soluble antigen fraction from Leishmania major leads to aggravation of murine leishmaniasis mediated by CD4+ T cells.

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901426-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Production of interferon gamma, interleukin 2, interleukin 4, and interleukin 10 by CD4+ lymphocytes in vivo during healing and progressive murine leishmaniasis

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901426-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Susceptibility to Leishmania major infection in interleukin-4-deficient mice

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901426-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Antigens targeted to the Leishmania phagolysosome are processed for CD4+ T cell recognition.

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901426-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Cytokine-induced synthesis of nitrogen oxides in macrophages: a protective host response to Leishmania and other intracellular pathogens

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901426-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Designer vaccines for parasitic diseases

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901426-5

7 January 2021

based on heuristic

inferred from DOI database lookup

The adjuvant effect of interleukin-12 in a vaccine against Leishmania major.

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901426-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Vaccine requirements for sustained cellular immunity to an intracellular parasitic infection

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901426-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Interleukin-12 (IL-12) enhancement of the cellular immune response against human immunodeficiency virus type 1 env antigen in a DNA prime/vaccinia virus boost vaccine regimen is time and dose dependent: suppressive effects of IL-12 boost are mediate

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901426-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Induction of CD8+ T cells using heterologous prime-boost immunisation strategies

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901426-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Enhanced CD8+ T cell response to HIV-1 env by combined immunization with influenza and vaccinia virus recombinants

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901426-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Boosting with recombinant vaccinia increases immunogenicity and protective efficacy of malaria DNA vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901426-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Recombinant viruses expressing a human malaria antigen can elicit potentially protective immune CD8+ responses in mice

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901426-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Pre-clinical development of a multi-CTL epitope-based DNA prime MVA boost vaccine for AIDS

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901426-5

7 January 2021

based on heuristic

inferred from DOI database lookup

New prospects for the development of a vaccine against human immunodeficiency virus type 1. An overview

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901426-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S1286-4579(01)01426-5

1 reference

Europe PubMed Central

26 November 2017

1 reference

Europe PubMed Central

26 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43698528&oldid=2102661349"